Jomaa Pharma GmbH today announced the presentation of the results of its recently completed clinical study In Gabon to treat acute malaria with its Non-Artemisinin-based Combination Therapy.
Read more … Jomaa Presents Clinical Study Results
Jomaa Pharma is developing a new drug against the malicious tropical disease – supported by Hamburg merchants. The perspectives are promising.
Read more … The Hamburg Malaria Project
Clinical study in Gabon shows high efficacy of the fosmidomycin-piperaquine combination in the treatment of malaria.
Read more … Clinical Update